NATR

Q: What is the price of Nature's Sunshine Products (NATR) today?

The current price of Nature's Sunshine Products (NATR) is $ 20.51, representing a 42.71% gain over the past year. The stock began the year trading around $ 21.58 and is currently priced at $ 20.51. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Nature's Sunshine Products (NATR) pay dividends?

Nature's Sunshine Products (NATR) did not pay dividends over the past year.

Nature's Sunshine Products Inc.

Price

$ 20.51

return (12m)

42.71%

p/e

17.85

p/bv

2.13

DIVIDEND YIELD

0.00%

NATR price

Nature's Sunshine Products

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment NATR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-7.63%

3 months

-15.97%

1 year

42.71%

2 years

37.10%

5 years

3.41%

10 years

117.20%

Fundamentals NATR

review the fundamentals of Nature's Sunshine Products shares

P/E

17.85

Sector: -3.94 Industry: -3.94

P/S (PSR)

0.72

Sector: -4.28 Industry: -4.28

P/BV

2.13

Sector: 1.87 Industry: 1.87

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

7.61%

Sector: -67.34% Industry: -67.34%

ROE

11.92%

Sector: -68.37% Industry: -68.37%

ROIC

21.20%

Sector: -2,920.39% Industry: -2,920.39%

NET MARGIN

4.06%

Sector: -41.59% Industry: -41.59%

GROSS MARGIN

72.71%

Sector: 36.47% Industry: 36.47%

OPERATING MARGIN

5.74%

Sector: -40.38% Industry: -40.38%

EV/EBITDA

7.97

Sector: -4.08 Industry: -4.08

EV/EBIT

11.46

Sector: -4.15 Industry: -4.15

PRICE-TO-ASSETS

1.36

Sector: 1.39 Industry: 1.39

BVPS

9.27

Sector: 1.80 Industry: 1.80

EPS

1.11

Sector: -2.21 Industry: -2.21

EQUITY-TO-ASSETS RATIO

0.64

Sector: 0.41 Industry: 0.41

LIABILITIES / ASSETS

0.36

Sector: 0.39 Industry: 0.39

CAGR REVENUE 5 YEARS

1.98%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

-7.17%

Sector: - Industry: -

FAIR VALUE OF Nature's Sunshine Products ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 20.51

Fair Value

$ 15.22

Upside Return potential.

-25.81%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals NATR

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JNJ	27.58	7.15	25.92%	2.18%	$ 580.26 B	21.83%
PFE	19.79	1.64	8.29%	6.61%	$ 148.19 B	11.83%
ABBV	110.65	-60.83	-54.98%	2.97%	$ 402.20 B	5.79%
NVO	10.02	6.09	60.73%	4.34%	$ 191.12 B	37.14%
MRK	33.42	6.50	19.45%	2.75%	$ 298.59 B	13.59%
AZN	27.73	6.08	21.93%	1.72%	$ 288.04 B	17.19%
GILD	17.41	6.85	39.33%	2.47%	$ 160.42 B	30.99%
BMY	16.04	5.81	36.19%	4.37%	$ 116.72 B	15.01%
ZTS	12.68	10.37	81.75%	2.59%	$ 33.52 B	27.79%
REGN	14.94	2.10	14.08%	0.57%	$ 66.09 B	29.65%
HALO	24.20	38.43	158.82%	0.00%	$ 8.44 B	23.13%
AMGN	24.20	20.54	84.87%	2.80%	$ 188.77 B	20.96%
MCK	19.85	-113.34	-570.98%	0.41%	$ 94.53 B	1.18%
HRMY	12.82	2.05	16.00%	0.00%	$ 1.87 B	16.20%
VRTX	26.16	5.86	22.41%	0.00%	$ 113.49 B	35.51%
CAH	31.09	-18.09	-58.20%	0.99%	$ 48.34 B	0.62%
ADMA	11.37	4.82	42.37%	0.00%	$ 1.88 B	32.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

NATR Historical Dividends

current DY: 0.00%

5-year average DY: 1.07%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	11/13/2012	11/26/2102	0,05000000
Dividends	03/25/2021	04/09/2021	1,00000000
Dividends	03/20/2017	04/03/2017	0,09470000
Dividends	11/21/2016	12/05/2016	0,09470000
Dividends	08/19/2016	09/02/2016	0,09470000
Dividends	05/23/2016	06/06/2016	0,09470000
Dividends	03/09/2016	03/22/2016	0,09470000
Dividends	11/16/2015	11/30/2015	0,09470000
Dividends	08/21/2015	09/08/2015	0,09470000
Dividends	05/20/2015	06/02/2015	0,09470000
Dividends	03/10/2015	03/23/2015	0,09470000
Dividends	11/18/2014	12/01/2014	0,09470000
Dividends	09/04/2014	09/19/2014	1,50000000
Dividends	08/14/2014	08/29/2014	0,10000000
Dividends	05/19/2014	06/02/2014	0,10000000
Dividends	03/26/2014	04/07/2014	0,10000000
Dividends	11/14/2013	11/29/2013	0,10000000
Dividends	08/15/2013	08/29/2013	1,60000000
Dividends	05/16/2013	05/30/2013	0,10000000
Dividends	03/14/2013	03/28/2013	0,10000000
Dividends	08/09/2012	08/23/2012	0,05000000
Dividends	05/16/2012	05/29/2012	0,05000000

ABOUT Nature's Sunshine Products

Nature's Sunshine Products Inc.

Average Investor10 user rating

4.0 (1 people)

United States

50 years

Founded: 1976

1980

Time since IPO - 46 years

837

Employees

Nature's Sunshine Products Inc. (United States) is listed on the Nasdaq and has a market capitalization of $355.03 Millions, with shareholders equity totaling $166.92 .

The company employs approximately 837 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Nature's Sunshine Products Inc. reported $489.79 in revenue, generating net income of $19.89 .

Key financial metrics include a P/E ratio of 17.85, a price-to-book (P/B) ratio of 2.13, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker NATR.

Market cap

$ 355.03 Millions

Net worth

$ 166.92

Assets

$ 261.46

Total Shares Outstanding

18.00

000

Average Daily Trading Volume

$ 104.92 Thousand

$ 104,916.00

Sector

Health Care

Industry

Biotechnology

NATR

NATR revenue and profits

Financial Results NATR

DRAG THE FRAME TO SEE MORE DATA

NATR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BFRA - Biofrontera

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

JNJ - Johnson & Johnson

$ 240.87 57,17% (12M)

P/E

27.58

2.18%

ROE

25.92%

P/BV

7.15

NVO - Novo Nordisk

$ 43.88 --42,37% (12M)

P/E

10.02

4.34%

ROE

60.73%

P/BV

6.09

ARGX - argenx

$ 893.52 54,62% (12M)

P/E

15.91

0.00%

ROE

22.64%

P/BV

3.60

MTP - Midatech Pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-10,615.69%

P/BV

0.01

PPD - PPD

$ - -0,00% (12M)

P/E

47.29

0.00%

ROE

-84.64%

P/BV

-40.03

ALNY - Alnylam Pharmaceuticals

$ 282.85 --8,16% (12M)

P/E

72.57

0.00%

ROE

53.68%

P/BV

38.95

GLPG - Galapagos NV

$ - -0,00% (12M)

P/E

4.50

0.00%

ROE

10.31%

P/BV

0.46